Results 141 to 150 of about 4,576,038 (327)

Weight gain on tenofovir alafenamide fumarate‐based therapy compared to tenofovir disoproxil fumarate‐ and abacavir‐based therapy in children and young people living with HIV in Europe

HIV Medicine, EarlyView.
Abstract Objective To compare BMI‐for‐age z‐score (zBMI) changes in treatment‐experienced children and young people living with HIV aged 6 to <25 years on tenofovir alafenamide fumarate (TAF) to those on tenofovir disoproxil fumarate (TDF) and abacavir (ABC).
The European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) Study Group, Siobhan Crichton, Hannah Castro, Katja Doerholt, Luminita Ene, Luisa Galli, Tessa Goetghebuer, Sannie Brit Nordly, Christoph Königs, Magdalena Marczynska, Andrea Marongiu, Lars Navér, Marisa Navarro, Antoni Noguera‐Julian, Paolo Paioni, Vana Spoulou, Vinicius Vieira, Charlotte Jackson, Intira Jeannie Collins, Ali Judd, Elizabeth Chappell, Laura Calle Miguel, Borja Guarch‐Ibáñez, John O'Rourke, Katia Prime, Beatriz Ruiz‐Saez, Sandra Soeria‐Atmadja, Anna Turkova   +27 more
wiley   +1 more source

Dyslipidemia in HIV-infected individuals

Brazilian Journal of Infectious Diseases, 2010
Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidemia associated with HIV infection and with the use of combined antiretroviral therapy includes elevations in triglycerides, reduced high-density ...
Eduardo Sprinz, Rosmeri Kuhmmer Lazzaretti, Regina Kuhmmer, Jorge Pinto Ribeiro   +3 more
doaj  

Remission of progressive multifocal leucoencephalopathy after antiretroviral therapy [PDF]

, 1997
Pere Domingo, Josep M. Guardiola, Álex Iranzo, N Margall   +3 more
openalex   +1 more source

Metabolic dysfunction‐associated liver disease predicts incident liver fibrosis in people with HIV mono‐infection: A cohort study

HIV Medicine, EarlyView.
Abstract Introduction Metabolic dysfunction‐associated liver disease (MASLD) might progress to cirrhosis. We aimed to evaluate the association of MASLD with the risk of developing clinically significant fibrosis (CSF) in people living with HIV (PLWH).
Juliana Fittipaldi, Sandra W. Cardoso, Estevão Portela Nunes, Cristiane Fonseca De Almeida, Patricia Dias De Brito, Valdilea G. Veloso, Beatriz Grinsztejn, Hugo Perazzo   +7 more
wiley   +1 more source

Prevention of HIV-1 infection with early antiretroviral therapy

Journal of family planning and reproductive health care, 2011
Michael Rayment
semanticscholar   +1 more source

The peripartum viral load cascade and outcomes of infants exposed to HIV in Lesotho

HIV Medicine, EarlyView.
Abstract Objectives This study describes the peripartum viral load (VL) monitoring cascade among individuals initiating antiretroviral therapy (ART) before delivery, as well as HIV testing, prophylaxis and outcomes of their infants in routine care in Lesotho, southern Africa.
Kathrin Haenggi, Moleboheng Mokebe, Lipontso Motaboli, Makobefo G. Chakela, Mpho Kao, Mathebe Kopo, Irene Ayakaka, Morongoe Nyakane, Tapiwa Tarumbiswa, Niklaus D. Labhardt, Jennifer A. Brown, Nadine Tschumi   +11 more
wiley   +1 more source

The association between HIV drug resistance testing, viral suppression and mortality in Ontario: a retrospective cohort study

HIV Medicine, EarlyView.
Abstract Background Drug resistance compromises the effectiveness of antiretroviral therapy (ART). Resistance testing prior to initiating therapy is recommended in guidelines in many high‐income countries, and it has been shown to improve outcomes after first‐line ART regimen failure. There is limited evidence on its role in treatment‐naïve individuals.
Lawrence Mbuagbaw, Carmen H. Logie, Lehana Thabane, Fiona Smaill, Marek Smieja, Ann N. Burchell, Beth Rachlis, Jean Eric Tarride, Abigail E. Kroch, Tony Mazzulli, Elizabeth Alvarez, Francis Nguyen, Richard Perez, Cristian Garcia, Jessyca Matos Silva, Hsien Seow   +15 more
wiley   +1 more source

Cardiovascular risk knowledge stratified by predicted cardiovascular risk level among people living with HIV attending a tertiary HIV care centre in Gaborone, Botswana: A cross‐sectional study

HIV Medicine, EarlyView.
Abstract Objectives While people living with HIV are at an increased risk of cardiovascular disease (CVD), the level of awareness of CVD risk in this population is not well documented. This study aimed to assess the association between CVD risk factor knowledge and estimated CVD risk among people living with HIV.
Bernard Morapedi, Onkabetse Julia Molefe‐Baikai, Onkarabile Hiri, Kago Kebotsamang, Thato Moshomo, Mosepele Mosepele   +5 more
wiley   +1 more source

The Unenlarged Lymph Nodes of HIV-1–infected, Asymptomatic Patients with High CD4 T Cell Counts Are Sites for Virus Replication and CD4 T Cell Proliferation. The Impact of Highly Active Antiretroviral Therapy [PDF]

, 1998
Klara Tenner‐Racz, Hans‐Jürgen Stellbrink, Jan van Lunzen, Claus Schneider, Jan-Peter Jacobs, Birgit Raschdorff, Gudrun Großschupff, Ralph M. Steinman, Paul Rácz   +8 more
openalex   +1 more source

Leukocyte count and new‐onset diabetes mellitus in people with HIV: A longitudinal study

HIV Medicine, EarlyView.
Abstract Objectives The risk of diabetes mellitus (DM) is increased in people with HIV. Chronic inflammation contributes to DM risk. High leukocytes are associated with DM in the general population, but in people with HIV, evidence of a leukocyte–DM association is limited. Methods We included participants of the Swiss HIV Cohort Study with new‐onset DM
Sophia C. Meyer, Zoe Klein, Isabella C. Schoepf, Christian W. Thorball, Marco Labarile, Neeltje A. Kootstra, Peter Reiss, Lene Ryom, Dominique L. Braun, Maria C. Thurnheer, Catia Marzolini, Christian R. Kahlert, Enos Bernasconi, Matthias Cavassini, Annalisa Marinosci, Jacques Fellay, Huldrych F. Günthard, Roger D. Kouyos, Bruno Ledergerber, Philip E. Tarr, the Swiss HIV Cohort Study, I Abela, K Aebi‐Popp, A Anagnostopoulos, M Battegay, E Bernasconi, DL Braun, HC Bucher, A Calmy, M Cavassini, A Ciuffi, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, CA Fux, HF Günthard, A Hachfeld, D Haerry, B Hasse, HH Hirsch, M Hoffmann, I Hösli, M Huber, D Jackson‐Perry, patient representatives, CR Kahlert, O Keiser, T Klimkait, RD Kouyos, H Kovari, K Kusejko, N Labhardt, K Leuzinger, B Martinez de Tejada, C Marzolini, KJ Metzner, N Müller, J Nemeth, D Nicca, J Notter, P Paioni, G Pantaleo, M Perreau, A Rauch, L Salazar‐Vizcaya, P Schmid, R Speck, M Stöckle, P Tarr, A Trkola, G Wandeler, M Weisser, S. Yerly   +75 more
wiley   +1 more source